TSE:CGY Calian Group Q1 2024 Earnings Report C$48.44 +1.11 (+2.35%) As of 05/2/2025 04:00 PM Eastern Earnings HistoryForecast Calian Group EPS ResultsActual EPSC$0.46Consensus EPS C$1.07Beat/MissMissed by -C$0.61One Year Ago EPSN/ACalian Group Revenue ResultsActual Revenue$179.18 millionExpected Revenue$167.90 millionBeat/MissBeat by +$11.28 millionYoY Revenue GrowthN/ACalian Group Announcement DetailsQuarterQ1 2024Date2/14/2024TimeN/AConference Call DateThursday, February 15, 2024Conference Call Time8:00AM ETConference Call ResourcesConference Call AudioConference Call TranscriptSlide DeckPress ReleaseEarnings HistoryCompany ProfileSlide DeckFull Screen Slide DeckPowered by Calian Group Q1 2024 Earnings Call TranscriptProvided by QuartrFebruary 15, 2024 ShareLink copied to clipboard.There are 8 speakers on the call. Operator00:00:00Good day and thank you for standing by. Welcome to the Calian Group First Quarter 20 24 Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Jennifer McCaughey, Director of Investor Relations. Operator00:00:31Please go ahead. Thank you, Shannon, and good morning, everyone. Thank you for joining us for Calyen's Q1 and Fiscal Year 20 24 Conference Call. Presenting this morning are Kevin Ford, Chief Executive Officer and Patrick Houston, Chief Financial Officer. As noted on Slide 2, please be advised that certain information discussed today is forward looking and subject to important risks uncertainties. Operator00:00:58The results predicted in these statements may be materially different from actual results. As a reminder, All amounts are expressed in Canadian dollars except as otherwise specified. With that, let me turn the call over to Kevin. Speaker 100:01:12Good morning, and thank you, Jennifer. I'd like to start by saying that you will increasingly hear me talk about Calyen on a consolidated basis. While we manage the different segments as distinct P and Ls, we're judging the performance of the company on a consolidated basis. Now for some Q1 highlights. We had a strong start to the year with revenues up 21%, driven by double digit organic growth and the contribution from 2 recent acquisitions. Speaker 100:01:42Organic growth outpaced M and A growth this quarter. Steps to improve our efficiency are bearing fruit with gross margin at an all time high of 32.5% and adjusted EBITDA margin bordering 11%. These results demonstrate the strength of our business model, our diversification in new markets and offerings as well as the value creation generated from our M and A agenda. In fact, our MA engine is working with the completion of 2 acquisitions in the past 6 months for a total consideration of approximately 100,000,000 Notable highlights in Q1 include the completion of the DECISIVE acquisition, which performed part a key part of our ITS strength in North America, And we welcome Michael Tremblay as President of our IT and Cyber Services Group. The contribution from our recent acquisition of Hawaii Pacific Teleport continues to be a highlight. Speaker 100:02:34And our sales engine was able to secure $150,000,000 in new signings this quarter. Given these strong results, We are reiterating our fiscal 2024 guidance, which puts us on track to deliver our 7th consecutive year of double digit profitable revenue growth. This strong performance is an early indicator of our path to reach $1,000,000,000 in revenues by the end of 26. Now I will turn it over to Patrick to discuss consolidated results and guidance for fiscal 2024. Over to you, Patrick. Speaker 200:03:06Thank you, Kevin. Q1 revenues reached $179,000,000 up 21% compared to the same period last year and represents the highest revenue quarter in our history. This increase was driven by growth across all four segments, including double digit growth in Health, ITCS and Advanced Technologies. Acquisitive growth was 9% was generated by the acquisitions of HPT and Decisive. Organic growth was 12% and was mainly driven by double digit growth in Health and Advanced Technologies. Speaker 200:03:37Our steps to restore efficiency are clearly working. Gross margin reached a record 32.5%, representing a 7th consecutive quarter above 30% and the first time above 32%. Adjusted EBITDA increased 37 percent to $20,000,000 driven by strength, Overall revenue growth and margin expansion in Advanced Technologies and Health as well as from benefits generated from the restructuring plan implemented midway through our Q4. Adjusted EBITDA margin reached 10.9 percent, up from 9.7% in the previous year. In Q1, we signed $150,000,000 in gross new contracts and ended the quarter with a backlog of $1,100,000,000 positioning us well for the balance of this year and into FY 2025. Speaker 200:04:24Net profit in Q1 increased to $5,500,000 or $0.46 per diluted share compared to $4,600,000 or $0.39 per share for the same period last year. The increase was mainly driven by higher adjusted EBITDA, partially offset by expenses relate to acquisitions and higher interest expenses as we drew on our credit facility to fund the acquisitions of HBT and Decisive. Note that in FY 'twenty four, we are expecting to pay the year to earn out for Symfrant. This amount is recorded on our balance sheet. We generated cash flow from operations of $18,000,000 in Q1, down from $25,000,000 last year. Speaker 200:05:02Working capital was neutral in the quarter, we had significant recapture in Q1 of last year. When we take working capital on our balance sheet and put it in relation to our revenue generation, We've made great strides in recent years. In FY 2020, we required $92,000,000 in working capital to generate $432,000,000 of revenue or 21% efficiency. In FY2023, we now required $90,000,000 to generate $659,000,000 of revenues or 14% efficiency. In Q1, we required $71,000,000 of working capital to generate the last 12 months of revenue of almost $700,000,000 or 10%. Speaker 200:05:39Going forward, we'll be looking to drive more efficiency in working capital as we continue to deliver double digit revenue growth. Operating free cash flow was up 17% to $14,000,000 and represented a 73% conversion from adjusted EBITDA. Looking at it through a shareholder lens, our operating free cash flow per share increased 15% to $1.20 per share. We continue to have a disciplined and balanced approach to capital deployment in the Q1. We invested in our business with the acquisition Decisive for $47,000,000 We also made CapEx investments of $2,000,000 Our CapEx levels have remained stable Despite significant increase in the size of our business over the last few years, we continue to invest in capital to help us scale and not inhibit our growth aspirations. Speaker 200:06:28We also provide a return to shareholders in the form of a dividend and share repurchases. We paid dividends of $3,000,000 or $0.28 per share, representing 23% of operating free cash flows. In Q1, we continued to repurchase shares through our NCIB program we put in place on September 1. We purchased 27,226 shares for cancellation for approximately $1,000,000 Since the launch of the NCIB plan, We've repurchased just under 60,000 shares for cancellation of approximately $3,000,000 Although we believe our share price remains undervalued, our capital allocation priority is still our M and A agenda. As a result, any future dividend increases or share repurchase decisions will be evaluated in the context of this while being mindful of our leverage. Speaker 200:07:18After making all these investments, we ended the quarter with a solid balance sheet. As of December 31, we had drawn $94,000,000 on our debt facility and we had net debt of $41,000,000 and a net debt to EBITDA ratio of 0.6 times, well below our target of 2.5 times. We maintain considerable debt capacity with our existing lenders in staying within our 2.5 times EBITDA leverage target to further fund our M and A agenda. Let's take a look at our guidance for FY 2024. Given our strong start to the year and our confidence for the balance of the year, we are reiterating our guidance. Speaker 200:07:55As a reminder, we expect revenues in the range of $730,000,000 to $790,000,000 for the year ended September 30, 2024. At the midpoint, this reflects revenue growth of 15%. This would represent our 7th consecutive year of double digit growth and record levels. In this guidance, the acquisitions of HPT and Decisive represent approximately 7% acquisitive growth over last year. At the midpoint of the range, organic growth would represent 8%. Speaker 200:08:26When taking into account Q1 revenues of $179,000,000 or $42,000,000 of backlogged earmarked for the remainder of FY 2024, our deferred revenues of $30,000,000 and our recurring revenue streams of approximately 30,000,000 We have 76% of FY 2024 already booked and ready to deliver. In terms of profitability, We expect adjusted EBITDA in the range of $83,000,000 to $89,000,000 At the midpoint, it reflects adjusted EBITDA growth of 30%, significantly outpacing our revenue growth. It's a result of expanding our business into higher margin areas as well as the full year benefit of our restructuring plan. It also implies a margin of 11.3%. With this guidance, we're on track to achieve another record year in FY 2024 are off to a great start to achieve our $1,000,000,000 revenue target by the end of FY twenty twenty six. Speaker 200:09:19As a reminder, we're expecting to see increased fluctuation in our quarterly results due to our revenue mix, which is more highly skewed towards products, where the timing of deliveries come into play as well as commercial customers characterized by greater demand variability. As always, we by greater demand variability. As always, we must caution that this guidance is ultimately dependent on the extent and timing of future contract awards and customer realization of existing contract vehicles. The guidance also implies no major changes to current economic environments, defense spending and supply chains as well as no major increases in interest rates or labor costs. Note that our guidance does not incorporate any additional M and A activity than those already mentioned and should we close any new opportunities, their contributions would be incremental. Speaker 200:10:06Finally, in terms of capital deployment for the year, earn out payments should be approximately $3,000,000 We continue to have a robust pipeline of acquisitions and we're working hard to a few of those in the balance of FY 2024. We expect to maintain our CapEx investments in the range of $8,000,000 to 10,000,000 and our current dividend at $1.12 per share. We believe this guidance reflects the strength of our business and momentum coming off a very strong quarter. I'll now turn the call back over to Kevin to provide color on our business segments. Kevin? Speaker 100:10:39Thank you, Patrick. Let me start with our ITCS segment. As mentioned, major highlights in this quarter include the start of Mike Tremblay as President and the acquisition of DECISIVE and continued margin recovery. Mike has been on board for about 2 months now and he's met with the teams in Ottawa, Toronto and Houston and has quickly assessed the people and assets we have. He is already implementing changes to our strategy and go to market business model, which is expected to just support higher sales generation. Speaker 100:11:10Recall that decisive closed December 1, so it's only contributed 1 month in our quarter. Early interactions with the excellent team as well as key customers have been positive And we believe this acquisition will be a great asset moving forward. When looking at our EBITDA margins, we are back in the 14% range to where we were at the beginning of last year. These are solid signs that the assets in our ITCS business are strong and I look forward to working with Mike to drive future growth across North America. We also entered Q1 with new contract signings of $62,000,000 an indication that bookings continue to be healthy. Speaker 100:11:47With the full year benefits and the cost reductions implemented in Q4 and the addition of Decisive, which complements and rounds out our current IT and Cyber Solutions portfolio in North America, we are well positioned to extract a lot of synergies over the next 24 months. Turning to our Health segment. The major highlights this quarter are the continued growth momentum both from a top line and profitability perspective, Digital Opportunities on the Horizon and Investments in Growth. We had a strong performance coming off of record Q4 with revenues up over 24% and adjusted EBITDA up 46%. This growth is all organic. Speaker 100:12:28We continue to experience strong demand from our long standing customers as well as short term health response demand which is characterized by higher margins. Furthermore, we're seeing exciting opportunities in our digital platform. We onboarded 2 customers so far and have a promising pipeline. These early wins reinforce our willingness to invest more and in fact we'll be investing in our sales capacity to get more feet on the street to sell both our service and digital product portfolio. With new contract signings of $40,000,000 and a solid backlog of $626,000,000 we believe that revenues of $200,000,000 per year are in sight for the first time in company's history. Speaker 100:13:05The M and A environment in health has improved and we are looking to deploy capital to further accelerate our growth in this segment. Turning to our Learning segment. As we mentioned last quarter, the pace of growth for Learning has started to slow down due to longer procurement decisions. However, we continue to see strong activity from existing customers, driven by global conflicts and a renewed focus on Readiness. What is exciting is that we are seeing some good defense opportunities, both domestically and globally, as well as in the commercial market. Speaker 100:13:37We recently hired a VP of Sales to help bring them to fruition. At the same time, we're also to invest in growth to make sure we are well positioned to capitalize on the macro environment where military training is mission critical. Believe the global defense market will yield future opportunities. It is just a matter of time. In the balance of the year, we will focus on upping our sales engine, unlocking opportunities and targeting acquisitions to strengthen our presence in Europe and complement our diversification and innovation strategy. Speaker 100:14:09Turning to our Advanced Tech segment. The major highlights for Advanced Tech this quarter are its continued growth momentum, especially with this product portfolio the solid contribution from Hawaii Pacific Teleport. We are pleased to see AT have a strong start to the year, continuing the momentum generated in the latter part of last year. Revenues increased 49 percent to $51,000,000 from $34,000,000 last year the segment was dealing with supply chain issues, this represents the 2nd consecutive quarter of the $50,000,000 mark for Advanced Technologies Group. This performance was driven in part by the Space segment, mainly from performance from our software business and the 1st full quarter contribution from HPT. Speaker 100:14:52This top line growth was also driven by terrestrial segment where our products portfolio including GNSS, AgTech and Nuclear continue to demonstrate significant growth. We have not spoken about defense and AT recently. However, we do see signs of increased demand as starts to finalize plans on large capital programs. It's just a matter of time before these opportunities turn to revenue. Given this higher volume and sales mix, gross margins hit an all time record above 36% and adjusted EBITDA more than doubled to 9,000,000 With continued strong demand for our products, the contribution from HPT, new contract signings of $44,000,000 and a solid backlog of 142,000,000 We expect to surpass the $200,000,000 revenue in FY 2024 again for the first time in company history. Speaker 100:15:41EBITDA margin should also increase given the higher margin HPT contribution and favorable revenue mix. Lastly, I wanted to announce that Patrick Thera, President of Advanced Technologies recently informed us that he will be retiring after a illustrious 38 year career with CalHEN. Patrick played a pivotal role in shaping of the Advanced Technology segment, I am immensely grateful for his dedication, stage counsel and commitment to the business. We will remain at the helm of the segment while we conduct a search for a successor and we look forward to working on a successful transition. In conclusion, I'd like to leave you with 3 key takeaways. Speaker 100:16:261, Our guidance reflects another double digit record year both on top line and adjusted EBITDA. Our Q1 results demonstrate that we are performing on track. We generated 12% organic growth in the quarter and 21% including acquisitions and converted that into 37% EBITDA growth. 2, our business model and strategy are working. We are on our way to the 7th consecutive year of record results have achieved this through challenges such as global conflicts, the pandemic, labor shortages, inflationary pressures and higher interest rates to name just a few. Speaker 100:17:02Our business is solid and growing. 3, we are a consistent capital deployer with an objective deploying over $100,000,000 per year. So far in fiscal 2024, we have deployed half of that with the decisive acquisition and have a robust M and A pipeline that we continue to pursue. We feel confident we have the opportunity to meet these objectives by the end of the year. The combination of M and A and organic growth coupled with our dedicated and talented team, continued investment in innovation across all that we do And the globalization of the company will position us to continue to sustain our track record as a double digit profitable growth company. Speaker 100:17:43On that note, I want to thank our staff for their commitments and dedication. They do make all the difference and are working extremely hard every day in support of our growth objectives. I also want to thank our customers for the loyalty, our suppliers for the collaboration and our shareholders for the continued support. And with that, Shannon, I'd like to now open the call for questions. Operator00:18:06Thank Our first question comes from the line of Doug Taylor with Canaccord. Your line is now open. Speaker 300:18:26Thank you. Good morning. I'd like to ask a question about the Advanced Technologies segment. The acquisitive growth related to HPT last year implies, I think, a revenue contribution, which would be well above what HPT was Producing or the run rate at the time of the acquisition. So I guess I wanted to speak to you about what's driving that. Speaker 300:18:47I understood that to be a largely recurring revenue business model. So to what degree is there a seasonal element to that? Or can you speak to success in cross selling or expanding the existing customer base there? Speaker 200:19:01Good morning, Doug. Yes, HBT has gotten off to a really strong start. We did win a project with a LEO operator And we're deploying all of that equipment for them. So there was a one time increase in revenue because of that project. But that recurring component of the business you mentioned continues to be very strong and we're continuing to see that growth. Speaker 200:19:23So I think so far it's been very positive. We want to commend the team there for great work and I think the teams are really meshing together. So I think from a cross sell, I think there's still Quite a lot of upside as the team start to get together and try to make some of those opportunities come to fruition. Speaker 300:19:42It's great to hear. Is that program, that project with the LEO operator now, I mean, the I guess one time are the hardware related parts of that program complete now or is that expected to extend here into the next couple of quarters? Speaker 200:19:58We expect it to go online here in our Q2 and start to deliver services on a recurring basis for that operator. So I think it's a big win for us. Speaker 300:20:08Okay. Shifting gears here, the ITCS business. First, I just wanted to speak about the organic growth profile and the demand profile there. I mean, we've heard from a lot of other issuers that the enterprise spending environment has been slow for a couple of quarters now. As you sit here today, can you speak to the near term outlook for better organic growth With that business as you roll out the new go to market strategy that under new leadership there? Speaker 100:20:39Doug, it's Kevin. Good morning. I think neutral deposit for sure, I think from an IT market perspective and you think in how we go to market value added resale, our consulting services, our cyber services, our managed services, we still see good demand. The commercial markets in the U. S, we We're doing this yesterday, over 1,000 customers. Speaker 100:21:00We're supporting in some shape or form, some smaller, some larger. Mike is really taking a regional model approach to this. So really focusing in on our regions that we believe there are growth opportunities and taking a customer first view into those regions. So a bit of a change in philosophy, I would say, and really trying to get close to those customers, including some of our largest customers. So Well, I support the other companies. Speaker 100:21:26I know there's some headwinds out there from an IT and expand, but we still see some very good opportunities. And I'm confident now with Mike and some of the changes he's made. And frankly, the team that's been there continues to work incredibly hard. And we'll soon see some organic growth Over IT, probably single digits and then continue to look for M and A opportunities to support more of a regional focus in certain areas that Mike wants to target. So Yes, I think it's positive. Speaker 100:21:51I think we'll continue to do well and coming out of the blocks. I'm excited where Mike and the team are trying to take IT going forward. Speaker 300:21:59Thanks. I'll save the rest for the investor event later today. I'll pass the line. Speaker 100:22:03Thanks, Doug. Thank Operator00:22:05you. Our next question comes from the line of Scott Fletcher with CIBC. Your line is now open. Speaker 400:22:13Good morning. I wanted to ask a question on the contribution from Decisive Group. I think we the idea was that there was pretty significant seasonality in that Q2 would be the strongest quarter. Is that still the case? Any changes to how we should be thinking about how Decisive will contribute going forward? Speaker 200:22:33Hey, Mark and Scott. Strong start. As Kevin mentioned, they were part of the Calian for a month, so they had a good 1st month. Q2 is still the this quarter. I think as we work with the team and try to re profile, I think we're seeing it a bit smoother throughout the year. Speaker 200:22:48So I think the second half will be stronger than maybe we indicated before, But some of that's coming off of Q2, but Q2 is still the strongest quarter with but maybe a bit less peaky than we said the previous time. Speaker 400:23:03Okay, thanks. That's helpful. And then just on the guidance On reiterating the guidance, I mean, a very strong Q1. Do you have more confidence about getting to the upper end of that guidance range now that you sort of have a strong Q1 in the book? Speaker 100:23:22Hi, good morning, Scott. It's Kevin. I think right now our guidance from our viewpoint is it represents I think we're going to have another strong year. We're going to have another double digit profitable growth year. I prefer not coming on specific ranges where we are At this point, just because I think coming out of Q1, reiterating our guidance, I think we're definitely still in that range. Speaker 100:23:44I think coming into Q2, we'll be in a better position to talk about where we're sitting in that range right now. We still have 3 quarters to go, so I don't want to get ahead of ourselves. That being said, the guidance we have issued will be another record year for Calyum. So very confident that we can achieve that. Speaker 400:24:00Fair enough. Thank you for that. Operator00:24:04Thank you. Our next question comes from the line of Rob Goff with Echelon Capital Markets. Your line is now open. Speaker 500:24:12Good morning and thank you for taking my question. My question will turn over to the health side. Could you I'll perhaps dive a little bit deeper into the increased demand. You referenced long standing customers and short term demands. Thank you. Speaker 100:24:26Yes, good morning. Yes, really what we're seeing is it's kind of coming from a few different areas, from our Defense legacy defense customer who we value really was the start of our healthcare business. We are seeing continued increased demand to support military requirements. So and that's right across all the different categories of support from healthcare that we provide the military. So definitely continued strong demand to support the military in support of their missions. Speaker 100:24:59The second one is on our psychological services. Now We've recently hired a new Chief Psychologist for the company and psychological services nationally as you know is a major issue. We are becoming very specialized in psychological services support to first responders for psychological support Military dealing with a whole bunch of different use cases, I can say it that way. And so our national psychological services presence is and we're seeing a lot of customers ping us on that now to support and we all recognize some of the challenges we're having in the health area these days. The third is just on our general clinician services piece. Speaker 100:25:40Again, strong demand. We see post COVID now that the Workforce is back. We're having more opportunity. We've invested in our recruiting engine. We're looking at pilots on AI and how we actually get at our medical network more effectively and I think that's paying dividends as well. Speaker 100:25:59And then our pharma business and our digital business are also well. So we continue to see new mandates for our patient support programs, contract research organization capability. And as I mentioned, we're actually to see some uptake now on our digital health portfolio. So the growth of the health business is not one thing. It is a few things that is happening in parallel. Speaker 100:26:19And Derek and the team are doing Great job. We've just invested in new sales. Nancy White just joined the company as the VP of Sales. So we're pretty excited about where we're going there. And as mentioned, that's all organic. Speaker 100:26:29So Very excited about where the healthcare business is today. Speaker 500:26:34Great. Thank you. And this is perhaps a bit too granular, but You made reference to the strength in cyber, both within the quarter and in the backlog. Is there anything further you could pick it up? Speaker 200:26:45Yes, cyber business continues to be probably the strongest one in our ITCS business. We're seeing we worked with a few of our customers that had breaches. We were able to help them recover their networks and we've continued to see strong Specifically in the healthcare market in Ontario, strong uptake for the services that we offer. So I think we're pretty optimistic that Our product and our offering right now is really hitting the right mark with our customers and we're optimistic that we can continue to expand that here in the coming Operator00:27:29Our next question comes from the line of Jonathan Lamers with Laurentian Bank Securities. Your line is now open. Speaker 600:27:37Good morning. Starting on the gross margin percentage, nice to see the New record level there for the quarter. Just at a high level, could you review some of the shifts in business mix that you see driving that? And How much of those are expected to continue over fiscal 2024? Speaker 200:27:58Good morning, Jonathan. Yes, I think it's I mean, this has been a concerted effort of ours for multiple years. I think it's been a combination of our M and A agenda doing acquisitions that are bringing in businesses at higher margin profiles. I think you saw that with Decisive. You're seeing that with HBT. Speaker 200:28:13I think that's contributing. We've been continuing to a lot of our investment has been going into our own products where we can drive higher products and that mix has continued to increase. I think it's probably multiple things, but I think all of them have been efforts we've been working on here for multiple years. And I think you're just starting to see that impact over time. So I think we're trying to keep it going and continue to accelerate that in the coming years and we're going to talk about that at the Investor Day. Speaker 100:28:39Yes. And it's Kevin. I'd echo Patrick's comments. The only thing I'd say and people that know me talk, know how I passionately am with the brand. I'm also seeing our brand get recognized now. Speaker 100:28:50Our brand is getting presence in our key markets. And while there's work to be done, we can establish the brand of successful delivery across mission critical functions and do it consistently, Whether it's emergency management, healthcare, IT, cyber, advanced technologies, learning missions, our brand is getting out there and with that The opportunity to increase margins despite the fact that people do want to work with Calyen in the most critical processes. So I think we're also starting to see the effect of that in our targeted Speaker 600:29:25Great. I'll leave more on that for the Investor Day. Just a question on the backlog. So if we look, versus this time last year, there's a couple of shifts. The health portion of the backlog like seems to be lower for this year sorry, a lot higher for this year rather sorry, up to $137,000,000 to be recorded in the balance of the year. Speaker 600:29:51The learning backlog is down a bit. Advanced tech, we've seen down a bit. So I guess two questions. One, is there anything In terms of seasonal timing going on there between health and learning, and could you just comment on how you expect that to expect to impact the results over the balance of the year? Speaker 200:30:15I'm not seeing an impact this year. I think the reality of both in health and learning, like we have several large contracts that We only re compete every 5 to 10 years. So we are burning those off, which you can see in the backlog. But I think the positive this quarter was strong signings, dollars 100 $1,000,000 in signings across the entire business. So that was a very positive note. Speaker 200:30:35And I don't think there's any dynamics there that are particularly concerning this year. I think It's going as we expected. Speaker 600:30:44Yes. Thank you. And just in Advanced Tech, the backlog is down just a little bit. Does that reflect the shift in business toward more short lead time type orders like GNS antennas away from longer term contracts or am I reading too much into that? Speaker 200:31:02No, I think you're right. The mix, well, I think that's where you're seeing in the margins. The mix more towards our products, which generally we're getting orders and delivering them within 6 to 8 weeks depending on any supply chain issues. And this is different than if you think 3, 4 years ago when much of the backlog was large ground system projects, which are multiyear projects, which bring longer backlogs. So I think it's just been a shift to the mix, but I think the positive has been the margin impact. Speaker 200:31:27I think you've seen that in the results. Speaker 600:31:31Okay. Thank you. And I noticed on the slides, it now says that you're targeting capital deployment of over $100,000,000 per year. Has that target moved up as you've introduced your new strategic plan? Speaker 200:31:45Yes. And that's going to be a highlight today at the Investor Day. So we're going to talk about how we increase the pace of our capital deployment. I think it's been a huge success for the company over the last 5 years. And part of getting to $1,000,000,000 is going to be continue to do the same thing we're doing, but at an increased pace. Speaker 200:32:00And I think that's going to be something we're going to dig into today at the Investor Day. Speaker 600:32:06Okay. Thanks for your comments. Speaker 400:32:08Thanks, Jonathan. Operator00:32:09Thank you. Our next question comes from the line of Michael Kyprios with Desjardins. Your line is now open. Speaker 700:32:17Good morning and congrats on the strong quarter. Maybe just on SG and A, it looks like sequentially it took a bit of a step up in the quarter. Was that main what was the main driver of this? And is there any way related to the acquisition? And should we expect to step back down as we approach the 2nd quarter? Speaker 200:32:36Yes. Good morning, Michael. More than half of that was really the acquisitions of HPT and DECISIVE. So, HPT in for a full quarter versus Q4 partially and then decisive coming in. So I think a lot of it's been just the acquisition impact. Speaker 200:32:50Also spending money kind of on our M and A pipeline right now that we're working And the rest was just kind of just more natural growth in line with revenue. Speaker 700:33:00Perfect. I appreciate it. And now that you have your full hands on decisive with the acquisition closing, do you have any maybe incremental tidbits that you've discovered since getting your hands on the business? Speaker 200:33:12I think so far so good. I mean, we really like this business. The team has been excellent. We've they're in Ottawa with us. And I think After meeting with the team, I think there's I think the similarities and being able to work together is evident. Speaker 200:33:26And I think that we've only The interaction so far have only reinforced that. So we're really looking forward to a positive year with the Deep. Speaker 700:33:35Appreciate it. Good luck with the Investor Day. Operator00:33:39Thank you. And I'm currently showing no further questions at this time. I'd like to hand the call back over to Kevin Ford for closing remarks. Speaker 100:33:46Thank you, Shannon, for facilitating today's call. It's very much appreciated. I'd like to mention, as you heard on the call that we'll be hosting our AGM and Investor Day today in Toronto. We're here at the Globe and Mail Center. We're actually doing this from the Globe and Mail Center this morning. Speaker 100:34:00So it's beautiful view, 17 floors above. So I'm hoping to see you folks and other folks on the call today, hope to see you here. So on that note, I'd like to thank each of you for attending and we look forward to providing you with an update on our next quarterly call. And with that, Shannon, we can close the call.Read morePowered by Conference Call Audio Live Call not available Earnings Conference CallCalian Group Q1 202400:00 / 00:00Speed:1x1.25x1.5x2x Earnings DocumentsSlide DeckPress Release Calian Group Earnings HeadlinesThe past three years for Calian Group (TSE:CGY) investors has not been profitableMarch 16, 2025 | finance.yahoo.comCalian Group's (TSE:CGY) Conservative Accounting Might Explain Soft EarningsFebruary 20, 2025 | finance.yahoo.comHere’s How to Claim Your Stake in Elon’s Private Company, xAII predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new millionaires than any tech advance in history. And for a limited time, you have the chance to claim a stake in this project, even though it’s housed inside Elon’s private company, xAI.May 3, 2025 | Brownstone Research (Ad)Public market insider buying at Calian Group (CGY)February 19, 2025 | theglobeandmail.comCalian Group targets $800M-$880M revenue in FY2025 with defense growth focusFebruary 13, 2025 | seekingalpha.comSerious Value: 3 TSX Stocks to Buy in the New YearFebruary 5, 2025 | ca.finance.yahoo.comSee More Calian Group Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Calian Group? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Calian Group and other key companies, straight to your email. Email Address About Calian GroupCalian Group (TSE:CGY) Ltd operates through four segments namely Advanced Technologies, Health, Learning, and Information Technology. It generates maximum revenue from the Health segment. The company serves health, defence, security, aerospace, engineering, AgTech, and IT industries. Its Health segment includes Clinical Services; Nursing Services; Psychological Services and Medical Property Management. The Advanced Technologies segment includes Engineering Solutions and Services; Nuclear and Environmental Services; Satcom; DOCSIS; Electronics Design and Manufacturing and Agricultural Technology.View Calian Group ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Amazon Earnings: 2 Reasons to Love It, 1 Reason to Be CautiousMeta Takes A Bow With Q1 Earnings - Watch For Tariff Impact in Q2Palantir Earnings: 1 Bullish Signal and 1 Area of ConcernMicrosoft Crushes Earnings, What’s Next for MSFT Stock?Qualcomm's Earnings: 2 Reasons to Buy, 1 to Stay AwayAMD Stock Signals Strong Buy Ahead of EarningsAmazon's Earnings Will Make or Break the Stock's Comeback Upcoming Earnings Palantir Technologies (5/5/2025)Vertex Pharmaceuticals (5/5/2025)Realty Income (5/5/2025)Williams Companies (5/5/2025)CRH (5/5/2025)Advanced Micro Devices (5/6/2025)American Electric Power (5/6/2025)Constellation Energy (5/6/2025)Marriott International (5/6/2025)Energy Transfer (5/6/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 8 speakers on the call. Operator00:00:00Good day and thank you for standing by. Welcome to the Calian Group First Quarter 20 24 Earnings Conference Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer Please be advised that today's conference is being recorded. I would now like to hand the conference over to your speaker today, Jennifer McCaughey, Director of Investor Relations. Operator00:00:31Please go ahead. Thank you, Shannon, and good morning, everyone. Thank you for joining us for Calyen's Q1 and Fiscal Year 20 24 Conference Call. Presenting this morning are Kevin Ford, Chief Executive Officer and Patrick Houston, Chief Financial Officer. As noted on Slide 2, please be advised that certain information discussed today is forward looking and subject to important risks uncertainties. Operator00:00:58The results predicted in these statements may be materially different from actual results. As a reminder, All amounts are expressed in Canadian dollars except as otherwise specified. With that, let me turn the call over to Kevin. Speaker 100:01:12Good morning, and thank you, Jennifer. I'd like to start by saying that you will increasingly hear me talk about Calyen on a consolidated basis. While we manage the different segments as distinct P and Ls, we're judging the performance of the company on a consolidated basis. Now for some Q1 highlights. We had a strong start to the year with revenues up 21%, driven by double digit organic growth and the contribution from 2 recent acquisitions. Speaker 100:01:42Organic growth outpaced M and A growth this quarter. Steps to improve our efficiency are bearing fruit with gross margin at an all time high of 32.5% and adjusted EBITDA margin bordering 11%. These results demonstrate the strength of our business model, our diversification in new markets and offerings as well as the value creation generated from our M and A agenda. In fact, our MA engine is working with the completion of 2 acquisitions in the past 6 months for a total consideration of approximately 100,000,000 Notable highlights in Q1 include the completion of the DECISIVE acquisition, which performed part a key part of our ITS strength in North America, And we welcome Michael Tremblay as President of our IT and Cyber Services Group. The contribution from our recent acquisition of Hawaii Pacific Teleport continues to be a highlight. Speaker 100:02:34And our sales engine was able to secure $150,000,000 in new signings this quarter. Given these strong results, We are reiterating our fiscal 2024 guidance, which puts us on track to deliver our 7th consecutive year of double digit profitable revenue growth. This strong performance is an early indicator of our path to reach $1,000,000,000 in revenues by the end of 26. Now I will turn it over to Patrick to discuss consolidated results and guidance for fiscal 2024. Over to you, Patrick. Speaker 200:03:06Thank you, Kevin. Q1 revenues reached $179,000,000 up 21% compared to the same period last year and represents the highest revenue quarter in our history. This increase was driven by growth across all four segments, including double digit growth in Health, ITCS and Advanced Technologies. Acquisitive growth was 9% was generated by the acquisitions of HPT and Decisive. Organic growth was 12% and was mainly driven by double digit growth in Health and Advanced Technologies. Speaker 200:03:37Our steps to restore efficiency are clearly working. Gross margin reached a record 32.5%, representing a 7th consecutive quarter above 30% and the first time above 32%. Adjusted EBITDA increased 37 percent to $20,000,000 driven by strength, Overall revenue growth and margin expansion in Advanced Technologies and Health as well as from benefits generated from the restructuring plan implemented midway through our Q4. Adjusted EBITDA margin reached 10.9 percent, up from 9.7% in the previous year. In Q1, we signed $150,000,000 in gross new contracts and ended the quarter with a backlog of $1,100,000,000 positioning us well for the balance of this year and into FY 2025. Speaker 200:04:24Net profit in Q1 increased to $5,500,000 or $0.46 per diluted share compared to $4,600,000 or $0.39 per share for the same period last year. The increase was mainly driven by higher adjusted EBITDA, partially offset by expenses relate to acquisitions and higher interest expenses as we drew on our credit facility to fund the acquisitions of HBT and Decisive. Note that in FY 'twenty four, we are expecting to pay the year to earn out for Symfrant. This amount is recorded on our balance sheet. We generated cash flow from operations of $18,000,000 in Q1, down from $25,000,000 last year. Speaker 200:05:02Working capital was neutral in the quarter, we had significant recapture in Q1 of last year. When we take working capital on our balance sheet and put it in relation to our revenue generation, We've made great strides in recent years. In FY 2020, we required $92,000,000 in working capital to generate $432,000,000 of revenue or 21% efficiency. In FY2023, we now required $90,000,000 to generate $659,000,000 of revenues or 14% efficiency. In Q1, we required $71,000,000 of working capital to generate the last 12 months of revenue of almost $700,000,000 or 10%. Speaker 200:05:39Going forward, we'll be looking to drive more efficiency in working capital as we continue to deliver double digit revenue growth. Operating free cash flow was up 17% to $14,000,000 and represented a 73% conversion from adjusted EBITDA. Looking at it through a shareholder lens, our operating free cash flow per share increased 15% to $1.20 per share. We continue to have a disciplined and balanced approach to capital deployment in the Q1. We invested in our business with the acquisition Decisive for $47,000,000 We also made CapEx investments of $2,000,000 Our CapEx levels have remained stable Despite significant increase in the size of our business over the last few years, we continue to invest in capital to help us scale and not inhibit our growth aspirations. Speaker 200:06:28We also provide a return to shareholders in the form of a dividend and share repurchases. We paid dividends of $3,000,000 or $0.28 per share, representing 23% of operating free cash flows. In Q1, we continued to repurchase shares through our NCIB program we put in place on September 1. We purchased 27,226 shares for cancellation for approximately $1,000,000 Since the launch of the NCIB plan, We've repurchased just under 60,000 shares for cancellation of approximately $3,000,000 Although we believe our share price remains undervalued, our capital allocation priority is still our M and A agenda. As a result, any future dividend increases or share repurchase decisions will be evaluated in the context of this while being mindful of our leverage. Speaker 200:07:18After making all these investments, we ended the quarter with a solid balance sheet. As of December 31, we had drawn $94,000,000 on our debt facility and we had net debt of $41,000,000 and a net debt to EBITDA ratio of 0.6 times, well below our target of 2.5 times. We maintain considerable debt capacity with our existing lenders in staying within our 2.5 times EBITDA leverage target to further fund our M and A agenda. Let's take a look at our guidance for FY 2024. Given our strong start to the year and our confidence for the balance of the year, we are reiterating our guidance. Speaker 200:07:55As a reminder, we expect revenues in the range of $730,000,000 to $790,000,000 for the year ended September 30, 2024. At the midpoint, this reflects revenue growth of 15%. This would represent our 7th consecutive year of double digit growth and record levels. In this guidance, the acquisitions of HPT and Decisive represent approximately 7% acquisitive growth over last year. At the midpoint of the range, organic growth would represent 8%. Speaker 200:08:26When taking into account Q1 revenues of $179,000,000 or $42,000,000 of backlogged earmarked for the remainder of FY 2024, our deferred revenues of $30,000,000 and our recurring revenue streams of approximately 30,000,000 We have 76% of FY 2024 already booked and ready to deliver. In terms of profitability, We expect adjusted EBITDA in the range of $83,000,000 to $89,000,000 At the midpoint, it reflects adjusted EBITDA growth of 30%, significantly outpacing our revenue growth. It's a result of expanding our business into higher margin areas as well as the full year benefit of our restructuring plan. It also implies a margin of 11.3%. With this guidance, we're on track to achieve another record year in FY 2024 are off to a great start to achieve our $1,000,000,000 revenue target by the end of FY twenty twenty six. Speaker 200:09:19As a reminder, we're expecting to see increased fluctuation in our quarterly results due to our revenue mix, which is more highly skewed towards products, where the timing of deliveries come into play as well as commercial customers characterized by greater demand variability. As always, we by greater demand variability. As always, we must caution that this guidance is ultimately dependent on the extent and timing of future contract awards and customer realization of existing contract vehicles. The guidance also implies no major changes to current economic environments, defense spending and supply chains as well as no major increases in interest rates or labor costs. Note that our guidance does not incorporate any additional M and A activity than those already mentioned and should we close any new opportunities, their contributions would be incremental. Speaker 200:10:06Finally, in terms of capital deployment for the year, earn out payments should be approximately $3,000,000 We continue to have a robust pipeline of acquisitions and we're working hard to a few of those in the balance of FY 2024. We expect to maintain our CapEx investments in the range of $8,000,000 to 10,000,000 and our current dividend at $1.12 per share. We believe this guidance reflects the strength of our business and momentum coming off a very strong quarter. I'll now turn the call back over to Kevin to provide color on our business segments. Kevin? Speaker 100:10:39Thank you, Patrick. Let me start with our ITCS segment. As mentioned, major highlights in this quarter include the start of Mike Tremblay as President and the acquisition of DECISIVE and continued margin recovery. Mike has been on board for about 2 months now and he's met with the teams in Ottawa, Toronto and Houston and has quickly assessed the people and assets we have. He is already implementing changes to our strategy and go to market business model, which is expected to just support higher sales generation. Speaker 100:11:10Recall that decisive closed December 1, so it's only contributed 1 month in our quarter. Early interactions with the excellent team as well as key customers have been positive And we believe this acquisition will be a great asset moving forward. When looking at our EBITDA margins, we are back in the 14% range to where we were at the beginning of last year. These are solid signs that the assets in our ITCS business are strong and I look forward to working with Mike to drive future growth across North America. We also entered Q1 with new contract signings of $62,000,000 an indication that bookings continue to be healthy. Speaker 100:11:47With the full year benefits and the cost reductions implemented in Q4 and the addition of Decisive, which complements and rounds out our current IT and Cyber Solutions portfolio in North America, we are well positioned to extract a lot of synergies over the next 24 months. Turning to our Health segment. The major highlights this quarter are the continued growth momentum both from a top line and profitability perspective, Digital Opportunities on the Horizon and Investments in Growth. We had a strong performance coming off of record Q4 with revenues up over 24% and adjusted EBITDA up 46%. This growth is all organic. Speaker 100:12:28We continue to experience strong demand from our long standing customers as well as short term health response demand which is characterized by higher margins. Furthermore, we're seeing exciting opportunities in our digital platform. We onboarded 2 customers so far and have a promising pipeline. These early wins reinforce our willingness to invest more and in fact we'll be investing in our sales capacity to get more feet on the street to sell both our service and digital product portfolio. With new contract signings of $40,000,000 and a solid backlog of $626,000,000 we believe that revenues of $200,000,000 per year are in sight for the first time in company's history. Speaker 100:13:05The M and A environment in health has improved and we are looking to deploy capital to further accelerate our growth in this segment. Turning to our Learning segment. As we mentioned last quarter, the pace of growth for Learning has started to slow down due to longer procurement decisions. However, we continue to see strong activity from existing customers, driven by global conflicts and a renewed focus on Readiness. What is exciting is that we are seeing some good defense opportunities, both domestically and globally, as well as in the commercial market. Speaker 100:13:37We recently hired a VP of Sales to help bring them to fruition. At the same time, we're also to invest in growth to make sure we are well positioned to capitalize on the macro environment where military training is mission critical. Believe the global defense market will yield future opportunities. It is just a matter of time. In the balance of the year, we will focus on upping our sales engine, unlocking opportunities and targeting acquisitions to strengthen our presence in Europe and complement our diversification and innovation strategy. Speaker 100:14:09Turning to our Advanced Tech segment. The major highlights for Advanced Tech this quarter are its continued growth momentum, especially with this product portfolio the solid contribution from Hawaii Pacific Teleport. We are pleased to see AT have a strong start to the year, continuing the momentum generated in the latter part of last year. Revenues increased 49 percent to $51,000,000 from $34,000,000 last year the segment was dealing with supply chain issues, this represents the 2nd consecutive quarter of the $50,000,000 mark for Advanced Technologies Group. This performance was driven in part by the Space segment, mainly from performance from our software business and the 1st full quarter contribution from HPT. Speaker 100:14:52This top line growth was also driven by terrestrial segment where our products portfolio including GNSS, AgTech and Nuclear continue to demonstrate significant growth. We have not spoken about defense and AT recently. However, we do see signs of increased demand as starts to finalize plans on large capital programs. It's just a matter of time before these opportunities turn to revenue. Given this higher volume and sales mix, gross margins hit an all time record above 36% and adjusted EBITDA more than doubled to 9,000,000 With continued strong demand for our products, the contribution from HPT, new contract signings of $44,000,000 and a solid backlog of 142,000,000 We expect to surpass the $200,000,000 revenue in FY 2024 again for the first time in company history. Speaker 100:15:41EBITDA margin should also increase given the higher margin HPT contribution and favorable revenue mix. Lastly, I wanted to announce that Patrick Thera, President of Advanced Technologies recently informed us that he will be retiring after a illustrious 38 year career with CalHEN. Patrick played a pivotal role in shaping of the Advanced Technology segment, I am immensely grateful for his dedication, stage counsel and commitment to the business. We will remain at the helm of the segment while we conduct a search for a successor and we look forward to working on a successful transition. In conclusion, I'd like to leave you with 3 key takeaways. Speaker 100:16:261, Our guidance reflects another double digit record year both on top line and adjusted EBITDA. Our Q1 results demonstrate that we are performing on track. We generated 12% organic growth in the quarter and 21% including acquisitions and converted that into 37% EBITDA growth. 2, our business model and strategy are working. We are on our way to the 7th consecutive year of record results have achieved this through challenges such as global conflicts, the pandemic, labor shortages, inflationary pressures and higher interest rates to name just a few. Speaker 100:17:02Our business is solid and growing. 3, we are a consistent capital deployer with an objective deploying over $100,000,000 per year. So far in fiscal 2024, we have deployed half of that with the decisive acquisition and have a robust M and A pipeline that we continue to pursue. We feel confident we have the opportunity to meet these objectives by the end of the year. The combination of M and A and organic growth coupled with our dedicated and talented team, continued investment in innovation across all that we do And the globalization of the company will position us to continue to sustain our track record as a double digit profitable growth company. Speaker 100:17:43On that note, I want to thank our staff for their commitments and dedication. They do make all the difference and are working extremely hard every day in support of our growth objectives. I also want to thank our customers for the loyalty, our suppliers for the collaboration and our shareholders for the continued support. And with that, Shannon, I'd like to now open the call for questions. Operator00:18:06Thank Our first question comes from the line of Doug Taylor with Canaccord. Your line is now open. Speaker 300:18:26Thank you. Good morning. I'd like to ask a question about the Advanced Technologies segment. The acquisitive growth related to HPT last year implies, I think, a revenue contribution, which would be well above what HPT was Producing or the run rate at the time of the acquisition. So I guess I wanted to speak to you about what's driving that. Speaker 300:18:47I understood that to be a largely recurring revenue business model. So to what degree is there a seasonal element to that? Or can you speak to success in cross selling or expanding the existing customer base there? Speaker 200:19:01Good morning, Doug. Yes, HBT has gotten off to a really strong start. We did win a project with a LEO operator And we're deploying all of that equipment for them. So there was a one time increase in revenue because of that project. But that recurring component of the business you mentioned continues to be very strong and we're continuing to see that growth. Speaker 200:19:23So I think so far it's been very positive. We want to commend the team there for great work and I think the teams are really meshing together. So I think from a cross sell, I think there's still Quite a lot of upside as the team start to get together and try to make some of those opportunities come to fruition. Speaker 300:19:42It's great to hear. Is that program, that project with the LEO operator now, I mean, the I guess one time are the hardware related parts of that program complete now or is that expected to extend here into the next couple of quarters? Speaker 200:19:58We expect it to go online here in our Q2 and start to deliver services on a recurring basis for that operator. So I think it's a big win for us. Speaker 300:20:08Okay. Shifting gears here, the ITCS business. First, I just wanted to speak about the organic growth profile and the demand profile there. I mean, we've heard from a lot of other issuers that the enterprise spending environment has been slow for a couple of quarters now. As you sit here today, can you speak to the near term outlook for better organic growth With that business as you roll out the new go to market strategy that under new leadership there? Speaker 100:20:39Doug, it's Kevin. Good morning. I think neutral deposit for sure, I think from an IT market perspective and you think in how we go to market value added resale, our consulting services, our cyber services, our managed services, we still see good demand. The commercial markets in the U. S, we We're doing this yesterday, over 1,000 customers. Speaker 100:21:00We're supporting in some shape or form, some smaller, some larger. Mike is really taking a regional model approach to this. So really focusing in on our regions that we believe there are growth opportunities and taking a customer first view into those regions. So a bit of a change in philosophy, I would say, and really trying to get close to those customers, including some of our largest customers. So Well, I support the other companies. Speaker 100:21:26I know there's some headwinds out there from an IT and expand, but we still see some very good opportunities. And I'm confident now with Mike and some of the changes he's made. And frankly, the team that's been there continues to work incredibly hard. And we'll soon see some organic growth Over IT, probably single digits and then continue to look for M and A opportunities to support more of a regional focus in certain areas that Mike wants to target. So Yes, I think it's positive. Speaker 100:21:51I think we'll continue to do well and coming out of the blocks. I'm excited where Mike and the team are trying to take IT going forward. Speaker 300:21:59Thanks. I'll save the rest for the investor event later today. I'll pass the line. Speaker 100:22:03Thanks, Doug. Thank Operator00:22:05you. Our next question comes from the line of Scott Fletcher with CIBC. Your line is now open. Speaker 400:22:13Good morning. I wanted to ask a question on the contribution from Decisive Group. I think we the idea was that there was pretty significant seasonality in that Q2 would be the strongest quarter. Is that still the case? Any changes to how we should be thinking about how Decisive will contribute going forward? Speaker 200:22:33Hey, Mark and Scott. Strong start. As Kevin mentioned, they were part of the Calian for a month, so they had a good 1st month. Q2 is still the this quarter. I think as we work with the team and try to re profile, I think we're seeing it a bit smoother throughout the year. Speaker 200:22:48So I think the second half will be stronger than maybe we indicated before, But some of that's coming off of Q2, but Q2 is still the strongest quarter with but maybe a bit less peaky than we said the previous time. Speaker 400:23:03Okay, thanks. That's helpful. And then just on the guidance On reiterating the guidance, I mean, a very strong Q1. Do you have more confidence about getting to the upper end of that guidance range now that you sort of have a strong Q1 in the book? Speaker 100:23:22Hi, good morning, Scott. It's Kevin. I think right now our guidance from our viewpoint is it represents I think we're going to have another strong year. We're going to have another double digit profitable growth year. I prefer not coming on specific ranges where we are At this point, just because I think coming out of Q1, reiterating our guidance, I think we're definitely still in that range. Speaker 100:23:44I think coming into Q2, we'll be in a better position to talk about where we're sitting in that range right now. We still have 3 quarters to go, so I don't want to get ahead of ourselves. That being said, the guidance we have issued will be another record year for Calyum. So very confident that we can achieve that. Speaker 400:24:00Fair enough. Thank you for that. Operator00:24:04Thank you. Our next question comes from the line of Rob Goff with Echelon Capital Markets. Your line is now open. Speaker 500:24:12Good morning and thank you for taking my question. My question will turn over to the health side. Could you I'll perhaps dive a little bit deeper into the increased demand. You referenced long standing customers and short term demands. Thank you. Speaker 100:24:26Yes, good morning. Yes, really what we're seeing is it's kind of coming from a few different areas, from our Defense legacy defense customer who we value really was the start of our healthcare business. We are seeing continued increased demand to support military requirements. So and that's right across all the different categories of support from healthcare that we provide the military. So definitely continued strong demand to support the military in support of their missions. Speaker 100:24:59The second one is on our psychological services. Now We've recently hired a new Chief Psychologist for the company and psychological services nationally as you know is a major issue. We are becoming very specialized in psychological services support to first responders for psychological support Military dealing with a whole bunch of different use cases, I can say it that way. And so our national psychological services presence is and we're seeing a lot of customers ping us on that now to support and we all recognize some of the challenges we're having in the health area these days. The third is just on our general clinician services piece. Speaker 100:25:40Again, strong demand. We see post COVID now that the Workforce is back. We're having more opportunity. We've invested in our recruiting engine. We're looking at pilots on AI and how we actually get at our medical network more effectively and I think that's paying dividends as well. Speaker 100:25:59And then our pharma business and our digital business are also well. So we continue to see new mandates for our patient support programs, contract research organization capability. And as I mentioned, we're actually to see some uptake now on our digital health portfolio. So the growth of the health business is not one thing. It is a few things that is happening in parallel. Speaker 100:26:19And Derek and the team are doing Great job. We've just invested in new sales. Nancy White just joined the company as the VP of Sales. So we're pretty excited about where we're going there. And as mentioned, that's all organic. Speaker 100:26:29So Very excited about where the healthcare business is today. Speaker 500:26:34Great. Thank you. And this is perhaps a bit too granular, but You made reference to the strength in cyber, both within the quarter and in the backlog. Is there anything further you could pick it up? Speaker 200:26:45Yes, cyber business continues to be probably the strongest one in our ITCS business. We're seeing we worked with a few of our customers that had breaches. We were able to help them recover their networks and we've continued to see strong Specifically in the healthcare market in Ontario, strong uptake for the services that we offer. So I think we're pretty optimistic that Our product and our offering right now is really hitting the right mark with our customers and we're optimistic that we can continue to expand that here in the coming Operator00:27:29Our next question comes from the line of Jonathan Lamers with Laurentian Bank Securities. Your line is now open. Speaker 600:27:37Good morning. Starting on the gross margin percentage, nice to see the New record level there for the quarter. Just at a high level, could you review some of the shifts in business mix that you see driving that? And How much of those are expected to continue over fiscal 2024? Speaker 200:27:58Good morning, Jonathan. Yes, I think it's I mean, this has been a concerted effort of ours for multiple years. I think it's been a combination of our M and A agenda doing acquisitions that are bringing in businesses at higher margin profiles. I think you saw that with Decisive. You're seeing that with HBT. Speaker 200:28:13I think that's contributing. We've been continuing to a lot of our investment has been going into our own products where we can drive higher products and that mix has continued to increase. I think it's probably multiple things, but I think all of them have been efforts we've been working on here for multiple years. And I think you're just starting to see that impact over time. So I think we're trying to keep it going and continue to accelerate that in the coming years and we're going to talk about that at the Investor Day. Speaker 100:28:39Yes. And it's Kevin. I'd echo Patrick's comments. The only thing I'd say and people that know me talk, know how I passionately am with the brand. I'm also seeing our brand get recognized now. Speaker 100:28:50Our brand is getting presence in our key markets. And while there's work to be done, we can establish the brand of successful delivery across mission critical functions and do it consistently, Whether it's emergency management, healthcare, IT, cyber, advanced technologies, learning missions, our brand is getting out there and with that The opportunity to increase margins despite the fact that people do want to work with Calyen in the most critical processes. So I think we're also starting to see the effect of that in our targeted Speaker 600:29:25Great. I'll leave more on that for the Investor Day. Just a question on the backlog. So if we look, versus this time last year, there's a couple of shifts. The health portion of the backlog like seems to be lower for this year sorry, a lot higher for this year rather sorry, up to $137,000,000 to be recorded in the balance of the year. Speaker 600:29:51The learning backlog is down a bit. Advanced tech, we've seen down a bit. So I guess two questions. One, is there anything In terms of seasonal timing going on there between health and learning, and could you just comment on how you expect that to expect to impact the results over the balance of the year? Speaker 200:30:15I'm not seeing an impact this year. I think the reality of both in health and learning, like we have several large contracts that We only re compete every 5 to 10 years. So we are burning those off, which you can see in the backlog. But I think the positive this quarter was strong signings, dollars 100 $1,000,000 in signings across the entire business. So that was a very positive note. Speaker 200:30:35And I don't think there's any dynamics there that are particularly concerning this year. I think It's going as we expected. Speaker 600:30:44Yes. Thank you. And just in Advanced Tech, the backlog is down just a little bit. Does that reflect the shift in business toward more short lead time type orders like GNS antennas away from longer term contracts or am I reading too much into that? Speaker 200:31:02No, I think you're right. The mix, well, I think that's where you're seeing in the margins. The mix more towards our products, which generally we're getting orders and delivering them within 6 to 8 weeks depending on any supply chain issues. And this is different than if you think 3, 4 years ago when much of the backlog was large ground system projects, which are multiyear projects, which bring longer backlogs. So I think it's just been a shift to the mix, but I think the positive has been the margin impact. Speaker 200:31:27I think you've seen that in the results. Speaker 600:31:31Okay. Thank you. And I noticed on the slides, it now says that you're targeting capital deployment of over $100,000,000 per year. Has that target moved up as you've introduced your new strategic plan? Speaker 200:31:45Yes. And that's going to be a highlight today at the Investor Day. So we're going to talk about how we increase the pace of our capital deployment. I think it's been a huge success for the company over the last 5 years. And part of getting to $1,000,000,000 is going to be continue to do the same thing we're doing, but at an increased pace. Speaker 200:32:00And I think that's going to be something we're going to dig into today at the Investor Day. Speaker 600:32:06Okay. Thanks for your comments. Speaker 400:32:08Thanks, Jonathan. Operator00:32:09Thank you. Our next question comes from the line of Michael Kyprios with Desjardins. Your line is now open. Speaker 700:32:17Good morning and congrats on the strong quarter. Maybe just on SG and A, it looks like sequentially it took a bit of a step up in the quarter. Was that main what was the main driver of this? And is there any way related to the acquisition? And should we expect to step back down as we approach the 2nd quarter? Speaker 200:32:36Yes. Good morning, Michael. More than half of that was really the acquisitions of HPT and DECISIVE. So, HPT in for a full quarter versus Q4 partially and then decisive coming in. So I think a lot of it's been just the acquisition impact. Speaker 200:32:50Also spending money kind of on our M and A pipeline right now that we're working And the rest was just kind of just more natural growth in line with revenue. Speaker 700:33:00Perfect. I appreciate it. And now that you have your full hands on decisive with the acquisition closing, do you have any maybe incremental tidbits that you've discovered since getting your hands on the business? Speaker 200:33:12I think so far so good. I mean, we really like this business. The team has been excellent. We've they're in Ottawa with us. And I think After meeting with the team, I think there's I think the similarities and being able to work together is evident. Speaker 200:33:26And I think that we've only The interaction so far have only reinforced that. So we're really looking forward to a positive year with the Deep. Speaker 700:33:35Appreciate it. Good luck with the Investor Day. Operator00:33:39Thank you. And I'm currently showing no further questions at this time. I'd like to hand the call back over to Kevin Ford for closing remarks. Speaker 100:33:46Thank you, Shannon, for facilitating today's call. It's very much appreciated. I'd like to mention, as you heard on the call that we'll be hosting our AGM and Investor Day today in Toronto. We're here at the Globe and Mail Center. We're actually doing this from the Globe and Mail Center this morning. Speaker 100:34:00So it's beautiful view, 17 floors above. So I'm hoping to see you folks and other folks on the call today, hope to see you here. So on that note, I'd like to thank each of you for attending and we look forward to providing you with an update on our next quarterly call. And with that, Shannon, we can close the call.Read morePowered by